SBI Securities
CDIO icon

SBI Securities’s Cardio Diagnostics CDIO Stock Holding History

SBI Securities’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19 Hold
10
– – ﹤0.01% 3919
2026
Q2 		$22 Hold
10
– – ﹤0.01% 3825
2026
Q1 		$20 Sell
10
-16
-62% -$42 ﹤0.01% 3764
2025
Q4 		$70 Sell
26
-1
-4% -$4 ﹤0.01% 3516
2025
Q3 		$108 Sell
27
-43
-61% -$170 ﹤0.01% 3491
2025
Q2 		$252 Buy
70
+9
+15% +$67 ﹤0.01% 3238
2025
Q1 		$601 Buy
61
+22
+56% +$343 ﹤0.01% 2792
2024
Q4 		$1.06K Buy
+39
New +$541 ﹤0.01% 2577

Other funds holding CDIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SBI Securities's CDIO Position: Q3 2026 in Review

SBI Securities held its Cardio Diagnostics (CDIO) position steady in Q3 2026 at 10 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

SBI Securities first reported a position in CDIO in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.06K in Q4 2024. 3 funds tracked by Wall St. Rank hold CDIO as of Q3 2026.

  • SBI Securities held 10 shares of Cardio Diagnostics worth $19 as of Q3 2026.
  • SBI Securities left its Cardio Diagnostics share count unchanged in Q3 2026.
  • Cardio Diagnostics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3919 holding.
  • SBI Securities first reported a position in Cardio Diagnostics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Cardio Diagnostics position peaked at $1.06K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.